Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days HK$15.42 HK$20.50 Friday, 10th May 2024 6855.HK stock ended at HK$20.10. This is 3.08% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.13% from a day low at HK$19.50 to a day high of HK$20.50.
90 days HK$15.42 HK$27.15
52 weeks HK$15.42 HK$28.15

Historical Ascentage Pharma Group International prices

Date Open High Low Close Volume
May 10, 2024 HK$19.60 HK$20.50 HK$19.50 HK$20.10 1 334 600
May 09, 2024 HK$19.30 HK$19.68 HK$19.30 HK$19.50 1 026 436
May 08, 2024 HK$19.32 HK$19.60 HK$18.70 HK$19.10 985 722
May 07, 2024 HK$18.52 HK$19.80 HK$18.52 HK$19.32 1 321 400
May 06, 2024 HK$18.22 HK$18.88 HK$18.22 HK$18.72 1 171 200
May 03, 2024 HK$18.44 HK$18.44 HK$18.04 HK$18.40 203 200
May 02, 2024 HK$17.02 HK$18.82 HK$17.00 HK$18.74 512 300
Apr 30, 2024 HK$17.72 HK$18.06 HK$17.54 HK$17.88 754 500
Apr 29, 2024 HK$17.58 HK$18.18 HK$17.32 HK$17.58 1 228 300
Apr 26, 2024 HK$17.30 HK$17.80 HK$17.30 HK$17.62 615 100
Apr 25, 2024 HK$17.22 HK$17.76 HK$16.98 HK$17.30 990 323
Apr 24, 2024 HK$16.96 HK$17.38 HK$16.70 HK$17.22 873 700
Apr 23, 2024 HK$16.58 HK$17.40 HK$16.50 HK$16.80 1 090 984
Apr 22, 2024 HK$15.84 HK$16.88 HK$15.70 HK$16.58 989 800
Apr 19, 2024 HK$16.66 HK$16.66 HK$15.42 HK$15.70 1 974 496
Apr 18, 2024 HK$16.82 HK$17.08 HK$16.50 HK$16.66 859 420
Apr 17, 2024 HK$16.82 HK$17.20 HK$16.72 HK$16.86 462 000
Apr 16, 2024 HK$16.94 HK$17.24 HK$16.58 HK$16.82 766 500
Apr 15, 2024 HK$17.82 HK$17.82 HK$16.94 HK$16.94 859 130
Apr 12, 2024 HK$18.16 HK$18.32 HK$17.82 HK$17.82 624 400
Apr 11, 2024 HK$18.08 HK$18.22 HK$17.70 HK$18.22 890 400
Apr 10, 2024 HK$18.26 HK$18.34 HK$17.86 HK$18.14 975 400
Apr 09, 2024 HK$17.20 HK$18.20 HK$17.20 HK$18.14 1 368 300
Apr 08, 2024 HK$17.18 HK$17.50 HK$17.00 HK$17.04 1 983 807
Apr 05, 2024 HK$17.02 HK$17.16 HK$16.50 HK$16.50 802 200
Click to get the best stock tips daily for free!

About Ascentage Pharma Group International

Ascentage Pharma Group International Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation, as well as for patients with tyrosine kinase inhibitor resistant chronic phase chronic myeloid leukemia. It als... 6855.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT